Pfizer amps up push into obesity treatments with $4.9B deal for Metsera
Pfizer is doubling down on obesity treatments by spending $4.9 billion on the development-stage drugmaker Metsera. The COVID-19 vaccine and treatment maker said early Monday that it will pay $47.5...
Read More






